Glasebach, Hanna M. Sc.

Cell and Tissue Technologies

Since 2020, Hanna Glasebach has been a research associate in the Innovation Field Cell and Tissue Technologies at Fraunhofer IGB. She studied biochemistry at the Eberhard Karls University of Tübingen and has been working on the establishment of  a 3D in-vitro skin model for the  validation of new targets for the treatment of psoriasis since her master's thesis.

    • Human 3D in-vitro test systems
    • Psoriatic skin models
    • Molecular cloning and development of cell lines
  • Professional career

    Since 2020 Research associate in the Innovation Field Cell and Tissue Technologies at Fraunhofer IGB
    2018 – 2020 M. Sc. (Biochemistry) at Eberhard Karls University, Tübingen
    2014 – 2018 B. Sc. (Biochemistry) at Eberhard Karls University, Tübingen
    2016 – 2017 Study abroad at Capital Normal University and Tsinghua University, Beijing, China
  • Project title short Funding source Period Project title long
    ImmuDarm Fraunhofer January 2022 – December 2024 human organ models for testing products against chronic inflammatory bowel disease
    Psoriceptors BMBF May 2020 – April 2022 Validation of innate immune receptors as targets for the treatment of psoriasis
    Immunsystem-to-go BMBF July 2019 – June 2022 Toll-like receptor assays – a new technology platform for Next Generation Immunoassays
  • DAAD scholarship
  • YEAR TITLE/AUTHOR
    2020 Hans, F., Glasebach, H., & Kahle, P. J. (2020). Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules. The Journal of biological chemistry, 295(3), 673–689.  https://doi.org/10.1074/jbc.RA119.010617